BFEC
RMD icon

Benjamin F. Edwards & Company’s ResMed RMD Stock Holding History

Benjamin F. Edwards & Company’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$7.48M Buy
39,069
+12,326
+46% +$2.5M 0.13% 177
2024
Q1 		$5.3M Buy
26,743
+25,841
+2,865% +$4.74M 0.1% 204
2023
Q4 		$155K Buy
902
+64
+8% +$9.83K ﹤0.01% 946
2023
Q3 		$124K Buy
838
+278
+50% +$50.3K ﹤0.01% 843
2023
Q2 		$122K Hold
560
– – ﹤0.01% 849
2023
Q1 		$123K Sell
560
-16
-3% -$3.47K 0.01% 843
2022
Q4 		$120K Sell
576
-68
-11% -$14.9K 0.01% 846
2022
Q3 		$141K Sell
644
-1
-0.2% -$228 0.01% 768
2022
Q2 		$135K Sell
645
-226
-26% -$48.1K 0.01% 777
2022
Q1 		$211K Buy
871
+528
+154% +$128K 0.01% 672
2021
Q4 		$89K Sell
343
-384
-53% -$99.6K ﹤0.01% 909
2021
Q3 		$192K Sell
727
-110
-13% -$30.1K 0.01% 668
2021
Q2 		$206K Sell
837
-42
-5% -$8.83K 0.01% 644
2021
Q1 		$171K Buy
879
+5
+0.6% +$1K 0.01% 713
2020
Q4 		$186K Buy
874
+176
+25% +$35.1K 0.01% 661
2020
Q3 		$120K Buy
698
+398
+133% +$73.5K 0.01% 701
2020
Q2 		$58K Hold
300
– – ﹤0.01% 859
2020
Q1 		$44K Sell
300
-610
-67% -$97.2K ﹤0.01% 875
2019
Q4 		$141K Buy
+910
New +$131K 0.01% 698

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Benjamin F. Edwards & Company's RMD Position: Q2 2024 in Review

Benjamin F. Edwards & Company increased its ResMed (RMD) stake by 46% in Q2 2024, buying an estimated $2.5M and bringing the position to 39,069 shares worth $7.48M. The position accounts for 0.13% of the portfolio, ranked #177.

Benjamin F. Edwards & Company first reported a position in RMD in Q4 2019 and has held it in 19 quarters since. 773 funds tracked by Wall St. Rank hold RMD as of Q2 2024.

  • Benjamin F. Edwards & Company held 39,069 shares of ResMed worth $7.48M as of Q2 2024.
  • Benjamin F. Edwards & Company bought 12,326 ResMed shares in Q2 2024, an estimated $2.5M.
  • ResMed made up 0.13% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #177 holding.
  • Benjamin F. Edwards & Company first reported a position in ResMed in Q4 2019 and has held it in 19 quarters since.
  • 773 funds tracked by Wall St. Rank held ResMed as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.